IPR

Topic 146 TM Prosecution Workshop

Topic 146 — Trademark Prosecution Workshop

TRADEMARK PROSECUTION involves taking a trademark application from FILING through EXAMINATION → ADVERTISEMENT → OPPOSITION (if any) → REGISTRATION. The Indian Trademark Registry processes ~470,000 applications annually with examination quality and objection rates rising significantly. Prosecution requires PRACTICAL EXPERTISE in: trademark searches; clearance opinions; examination response strategy; objection handling under Sections 9 + 11; opposition response; oral hearings; appeals to HC IP Divisions. The framework operates under Trade Marks Act 1999 + Trade Marks Rules 2017 + amendments (2019, 2020). Critical recent developments: SUN PHARMA v. DABUR (Del HC 9 February 2024, CA(COMM.IPD-TM) 146/2022) — Rule 45 timelines NOT EXTENDABLE under Section 131; reinforces strict opposition timelines. Successful trademark prosecution requires: comprehensive PRE-FILING CLEARANCE; strong DISTINCTIVENESS arguments; consistent USE EVIDENCE with affidavits; coherent BRAND NARRATIVE; ANTICIPATING OPPOSITION risks early. Common objection grounds: SECTION 9(1)(a) devoid of distinctive character; SECTION 9(1)(b) descriptive; SECTION 9(1)(c) customary; SECTION 11(1) similar to earlier mark; SECTION 11(2) reputed mark conflict. Opposition timelines are STRICT — 4 months from journal advertisement (non-extendable); 2 months for counter-statement; 2 months each for evidence under Rules 45-47. Appeals lie to HC IP Divisions (post-IPAB abolition under Tribunals Reforms Act 2021). Recent watershed cases: PERNOD RICARD v. KARANVEER (2025 INSC 981) composite test; CADILA HEALTHCARE 2001 confusion test (reaffirmed); MARS v. CADBURY "CELEBRATIONS" (2025 Del HC) Mediation Act 2023 settlement; WOW MOMO v. WOW BURGER (2025 Del HC) composite marks; TOSHIBA v. TOSIBA (2024 Del HC) trademark seniority; ITC v. BRITANNIA (2017) trade dress. Madrid Protocol integration (since 2013) provides international framework. This topic walks through every aspect of trademark prosecution — search, examination response, opposition handling, hearings, evidence strategy, and recent reforms.

1. Trademark Prosecution — Foundational Framework

A. The Prosecution Lifecycle

Trademark Prosecution Lifecycle

1. PRE-FILING CLEARANCE · TM search (Indian + international). · Domain name + corporate search. · Common law search. · Risk assessment. 2. APPLICATION FILING (Section 18) · Form TM-A. · Class identification (Nice). · Use claim (if applicable). 3. EXAMINATION (Section 18 + 9 + 11) · Examiner Report typically 12-18 months. · Absolute + relative grounds. 4. EXAMINATION RESPONSE · 30 days from receipt. · Address each objection. · Distinctiveness arguments. · Use evidence. 5. HEARING (if needed) · Oral arguments. · Examiner satisfaction. 6. ADVERTISEMENT (Section 20) · Trade Marks Journal. · Triggers opposition window. 7. OPPOSITION (Section 21) · 4 months from journal advertisement (NON-EXTENDABLE). · Form TM-O. 8. COUNTER-STATEMENT · 2 months from notice. · Failure → application abandoned. 9. EVIDENCE STAGES (Rules 45-47) · Opponent's evidence (Rule 45). · Applicant's evidence (Rule 46). · Opponent's rejoinder (Rule 47). 10. HEARING + DECISION · Registrar's order. 11. APPEAL · HC IP Division (post-IPAB). · 3 months.

2. Pre-Filing Clearance Search

A. Search Strategy

Comprehensive Trademark Search

1. INDIAN TRADE MARKS REGISTRY SEARCH · IPO Trade Mark Public Search. · Class-wise searching. · Phonetic, visual, conceptual similarity. · Status check (registered, pending, abandoned). 2. INTERNATIONAL SEARCHES · Madrid Monitor. · WIPO Global Brand Database. · Foreign IPO databases. · Cross-jurisdictional risks. 3. COMMON LAW SEARCHES · Trade name databases. · Corporate registration. · Domain name databases. · Web/social media presence. 4. INDUSTRY-SPECIFIC SEARCHES · Industry directories. · Brand monitoring. · Trade publications. 5. CLEARANCE OPINION · Risk assessment matrix. · Strong vs. moderate vs. weak risks. · Recommendation: file as-is, modify, or abandon. · Common law passing off considerations. KEY CONSIDERATIONS: · Phonetic similarity (Cadila 2001 framework). · Visual similarity. · Conceptual similarity. · Goods/services overlap. · Channel of trade.

3. Examination Response

A. Common Objection Categories

Objection

Section

Response Strategy

Devoid of distinctive character

Section 9(1)(a)

Acquired distinctiveness through use; logo distinctiveness.

Descriptive

Section 9(1)(b)

Secondary meaning evidence; suggestive vs descriptive.

Customary in trade

Section 9(1)(c)

Distinguishing features; trade evidence.

Marks of nature/deceiving

Section 9(2)(a)

Distinctive features; non-deceptive use.

Religious sentiments

Section 9(2)(b)

Non-religious context; cultural awareness.

Scandalous/obscene

Section 9(2)(c)

Objective standards; cultural context.

Identical/similar earlier mark

Section 11(1)

Distinguishing features; consent letter.

Conflict with reputed mark

Section 11(2)

Coexistence agreements; distinct fields.

Use prohibited by law

Section 11(3)

Lawful use evidence.

B. Distinctiveness Arguments

Building Distinctiveness Arguments

1. INHERENT DISTINCTIVENESS · Coined/fanciful marks (e.g., XEROX, KODAK). · Arbitrary marks (e.g., APPLE for computers). · Suggestive marks (e.g., COPPERTONE for sunscreen). 2. ACQUIRED DISTINCTIVENESS · Long, continuous use. · Substantial advertising spend. · Sales volume + market share. · Public recognition surveys. · Media coverage. · Awards + recognition. 3. EVIDENCE FOR ACQUIRED DISTINCTIVENESS · User affidavit (formal statement of first use date + continuous use). · Invoices showing use. · Advertisements (print + digital). · Marketing budget records. · Sales figures (audited). · Website screenshots over time. · Social media presence. · Newspaper/magazine articles. · Customer testimonials. · Industry awards. 4. SECTION 32 PROVISO · Distinctive character through use. · Strong evidence base required. · Affidavit + supporting documents. 5. CONTEXTUAL ANALYSIS · Goods/services context. · Consumer perception. · Industry standards.

4. Opposition Response Strategy

A. Opposition Timeline (Strict — 2024 Sun Pharma Reaffirmation)

📖 Sun Pharma Laboratories Ltd. v. Dabur India Ltd., C.A.(COMM.IPD-TM) 146/2022 (Del HC 9 February 2024)

Facts — Counter-statement served late (1 month delay) under Rule 45 (now Rule 50).

Holding — Delhi HC: Rule 45 timelines NOT EXTENDABLE under Section 131. Strict timelines essential.

Significance — Reinforces strict opposition timelines. Repeated extensions defeat statutory purpose.

Lesson — DO NOT MISS opposition deadlines.

B. Counter-Statement Drafting

Counter-Statement Best Practices

TIMELINE: 2 months from notice (NON-EXTENDABLE per Sun Pharma 2024). STRUCTURE: 1. INTRODUCTION · Application details. · Date of advertisement. · Opposition received. 2. DENIAL OF ALLEGATIONS · Para-wise denial of opposition grounds. · Specific admission and denial (Order VIII Rule 3-5 CPC). · Per Thangam v. Navamani Ammal (2024 LiveLaw (SC) 188). 3. AFFIRMATIVE DEFENCES · Distinctiveness arguments. · Use evidence. · Lack of confusion arguments. · Different goods/services. · Coexistence in market. 4. PRELIMINARY OBJECTIONS · Locus standi. · Limitation issues. · Procedural irregularities. 5. RELIEF SOUGHT · Dismiss opposition. · Allow registration. 6. VERIFICATION · Sworn statement. FAILURE TO FILE = AUTOMATIC ABANDONMENT.

C. Evidence Stages (Rules 45-47)

Stage

Rule

Timeline

Content

Opponent's Evidence

Rule 45

2 months from counter-statement

Evidence in support of opposition.

Applicant's Evidence

Rule 46

2 months from Rule 45 evidence

Evidence in support of registration.

Opponent's Rejoinder

Rule 47

1 month from Rule 46 evidence

Strictly rebuttal; no new matter.

D. Evidence Types

  • User affidavit (date of first use, continuous use).
  • Invoices showing use (oldest available).
  • Advertisements (print + digital + TV).
  • Marketing materials.
  • Sales figures (audited).
  • Industry awards/recognition.
  • Survey evidence (consumer recognition).
  • Coexistence search reports (peaceful coexistence in market).
  • Foreign registrations.
  • Trademark registrations in related classes.

5. Hearing Preparation

A. Pre-Hearing Strategy

  • Comprehensive written submissions filed first.
  • Bundle of authorities prepared.
  • Comparison charts (mark vs. cited mark).
  • Goods/services analysis.
  • Coexistence search report (similar marks in market).
  • Cadila 2001 framework prepared.
  • Pernod Ricard 2025 composite test analysis.

B. Hearing Procedure

  • Applicant opens with brief statement.
  • Examiner/opponent identifies objections/grounds.
  • Applicant addresses each.
  • Cross-examination (in opposition).
  • Re-examination.
  • Closing arguments.
  • Order reserved.

6. Recent Trademark Cases for Prosecution

📖 Pernod Ricard India v. Karanveer Singh Chhabra, 2025 INSC 981

Facts — Composite trademarks "BLENDERS PRIDE", "IMPERIAL BLUE" vs. "LONDON PRIDE".

Holding — Supreme Court (August 2025): COMPOSITE TEST refined; Cadila 2001 reaffirmed over Dyechem 2000.

Significance — Modern composite mark analysis framework; reinforces multi-factor confusion test.

Lesson — Use multi-factor approach; Cadila 7-factor framework.

📖 Cadila Health Care v. Cadila Pharmaceuticals, (2001) 5 SCC 73; AIR 2001 SC 1952

Facts — Cadila names confusion in pharma.

Holding — Supreme Court: Multi-factor composite test for confusion.

Seven Factors: 1. Nature of marks. 2. Degree of resemblance. 3. Nature of goods. 4. Class of purchasers. 5. Mode of purchase. 6. Marketing channels. 7. Any other relevant circumstances.

Significance — FOUNDATIONAL composite test; reaffirmed by Pernod Ricard 2025.

📖 Mars v. Cadbury "CELEBRATIONS", 2025 (Del HC)

Facts — 25-year trademark dispute.

Outcome — Court-annexed mediation under Mediation Act 2023.

Significance — Mediation Act 2023 in operation; coexistence agreements.

7. Madrid Protocol Integration

A. India as Office of Origin

  • Indian applicants file Indian application first.
  • Then international application via WIPO.
  • Designations to other Madrid members.
  • Indian Registry handles transmission.
  • Trade Marks Rules 2017 framework.

B. India as Designated Country

  • Foreign applicants designate India.
  • Indian Registry examines under Indian law.
  • 12-18 month refusal period.
  • National opposition procedure available.
  • Refusal/acceptance communicated to WIPO.

C. Strategic Considerations

  • Cost-effective for multi-country protection.
  • Single application + management.
  • Single renewal cycle.
  • Subject to "central attack" (5-year vulnerability).
  • India ranks 7-8 globally in Madrid filings.

8. Strategic Considerations

For trademark applicants — eight points

For pre-filing, conduct comprehensive clearance search.

For descriptive marks, build acquired distinctiveness evidence.

For oppositions, file counter-statement within 2 months (Sun Pharma 2024 strict).

For evidence, file within Rule 45-47 strict deadlines.

For hearings, prepare comprehensive written submissions first.

For Madrid filings, leverage cost-effective international protection.

For coexistence, leverage peaceful market coexistence evidence.

For appeals, file to HC IP Division within 3 months.

9. Memory Aid — Quick Recall

Quick Recall — Trademark Prosecution

Trade Marks Act 1999 + Rules 2017 + 2019/2020 amendments.

Section 18 — Application; Form TM-A.

Section 9 — Absolute Grounds; Section 11 — Relative Grounds.

Section 20 — Advertisement in Journal.

Section 21 — Opposition within 4 months (NON-EXTENDABLE).

Form TM-O — both for opposition + counter-statement.

Counter-statement: 2 months (NON-EXTENDABLE per Sun Pharma 2024).

Rule 45 — Opponent's evidence (2 months).

Rule 46 — Applicant's evidence (2 months).

Rule 47 — Opponent's rejoinder (1 month).

Section 25 — 10-year term renewable.

Section 47 — Non-use removal (5 years).

Sun Pharma v. Dabur (Del HC 9 February 2024) — Rule 45 strict.

Cadila Health Care 2001 — 7-factor composite test.

Pernod Ricard 2025 INSC 981 — composite test reaffirmed.

Mars v. Cadbury 2025 — Mediation Act 2023 settlement.

🎯 EXAM POINTERS — TOPIC 146

  • Trade Marks Act 1999 + Rules 2017 + 2019/2020 amendments.
  • Section 18 — Application; Form TM-A.
  • Section 9 — Absolute Grounds (distinctive character; descriptive; customary; deceptive; religious; scandalous).
  • Section 11 — Relative Grounds (identical/similar; reputation; other law; consent).
  • Section 20 — Advertisement in Trade Marks Journal.
  • Section 21 — Opposition within 4 months from advertisement (NON-EXTENDABLE).
  • Section 23 — Registration.
  • Section 25 — 10-year term renewable.
  • Section 47 — Non-use removal (5 years).
  • Section 91-92 — Appeal to HC IP Division (post-IPAB).
  • Form TM-O — Opposition + counter-statement.
  • Counter-statement: 2 months (NON-EXTENDABLE).
  • Rule 45 — Opponent's evidence (2 months).
  • Rule 46 — Applicant's evidence (2 months).
  • Rule 47 — Opponent's rejoinder (1 month, strictly rebuttal).
  • Sun Pharma v. Dabur (Del HC 9 February 2024, CA(COMM.IPD-TM) 146/2022) — Rule 45 timelines NOT extendable.
  • Cadila Health Care v. Cadila Pharmaceuticals (2001 5 SCC 73) — 7-factor composite test.
  • Pernod Ricard v. Karanveer (2025 INSC 981) — composite test reaffirmed; Cadila over Dyechem.
  • Mars v. Cadbury "CELEBRATIONS" (2025 Del HC) — Mediation Act 2023 settlement.
  • WOW Momo v. WOW Burger (2025 Del HC) — composite marks + secondary meaning.
  • Toshiba v. Tosiba Appliances (2024 Del HC) — 50-year trademark seniority.
  • Section 32 — Acquired distinctiveness through use.
  • Madrid Protocol member since 8 July 2013.
  • Tribunals Reforms Act 2021 — IPAB abolition; HC IP Divisions.
  • Thangam v. Navamani Ammal (2024 LiveLaw (SC) 188) — para-wise denial requirement.